Immunotherapeutic approaches for Alzheimer’s disease in transgenic mouse models
✍ Scribed by Thomas Wisniewski; Allal Boutajangout
- Publisher
- Springer
- Year
- 2009
- Tongue
- English
- Weight
- 352 KB
- Volume
- 214
- Category
- Article
- ISSN
- 0340-2061
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The cerebral deposition of amyloid β‐peptide, a central event in Alzheimer's disease (AD) pathogenesis, begins several years before the onset of clinical symptoms. Noninvasive detection of AD pathology at this initial stage would facilitate intervention and enhance treatment success. In
Novel gene technologies have allowed us to manipulate the genetic balance of candidate molecules in mice in a controllable manner. Homologous or site-speci®c recombination in embryonic stem cells allows us to study the consequences of de®ciencies, mutations, and conditional or tissue-speci®c express